SCHEMBL7089072

SCHEMBL7089072

FC(F)(F)Oc1cccc(-c2ccc3cc[nH]c3c2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 3/20 0.54
XDH P47989 1/20 0.47
DHODH Q02127 1/20 0.46
PRMT5 O14744 1/20 0.43
WDR77 Q9BQA1 1/20 0.43
HDAC6 Q9UBN7 1/20 0.42
MEN1 O00255 1/20 0.41
POLB P06746 1/20 0.41
MAPK1 P28482 1/20 0.41
KMT2A Q03164 1/20 0.41
NPC1 O15118 1/20 0.41
CHRNB4 P30926 1/20 0.41
CHRNA3 P32297 1/20 0.41
CHRNA7 P36544 1/20 0.41
CHRNA10 Q9GZZ6 1/20 0.41
CHRNA9 Q9UGM1 1/20 0.41
GALR1 P47211 1/20 0.41
FFAR1 O14842 1/20 0.41
FFAR4 Q5NUL3 1/20 0.41
AHR P35869 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28030810 0.88 NPC1 (0.57) GHSRXDHDHODHNPC1CHRNB4
SCHEMBL3860188 0.86 GHSR (0.51) GHSRMEN1POLBMAPK1KMT2A
SCHEMBL981786 0.82 MEN1 (0.59) GHSRMEN1POLBMAPK1KMT2A
SCHEMBL30278196 0.82 MEN1 (0.59) GHSRMEN1POLBMAPK1KMT2A
SCHEMBL2278582 0.80 MEN1 (0.67) GHSRXDHDHODHPRMT5WDR77
SCHEMBL7085478 0.75 XDH (0.46) GHSRXDHDHODHGALR1AHR
SCHEMBL6326839 0.75 ASH1L (0.51) XDHDHODHKCNH2SCN10AABL1
SCHEMBL858340 0.75 CDK8 (0.58) MAPK1ABL1
SCHEMBL7087919 0.74 AHR (0.63) GHSRNPC1CHRNB4CHRNA3CHRNA7
SCHEMBL7088159 0.74 NPC1 (0.67) GHSRNPC1CHRNB4CHRNA3CHRNA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030203959-A1 Novel modulators of potassium channels 4SC AG (DE) 2003-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030203959-A1 Novel modulators of potassium channels HCN3, KCNN3, KCNN1 GHSR 238/4885XDH 2112/4885DHODH 2706/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.